Last reviewed · How we verify
NCT06292260: MIND-the-SKIN2
Digital Toolkit for Skin Diseases in LMICs: Part 2
NA trial testing mHealth app in Skin Diseases in 1,000 participants. Currently enrolling.
31 May 2026
Quick facts
| Lead sponsor | Tulane University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 1,000 |
| Start date | 18 March 2024 |
| Primary completion | 31 May 2026 |
| Estimated completion | 31 May 2026 |
| Sites | 1 location across Côte d’Ivoire |
Drugs / interventions tested
- mHealth app
Conditions studied
- Skin Diseases — all drugs for Skin Diseases →
Sponsor
Tulane University
Who can join
18 and older, any sex, with Skin Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Impact evaluation of eSkinHealth in improving case detection of skin NTDs and treatment outcomes in rural and urban settings
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06292260
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of mHealth app
Trials testing the same drug.
- NCT04239911 — Leveraging Home Health Aides to Improve Outcomes in Heart Failure · NA · completed
- NCT06361056 — Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials · NA · completed
- NCT05300399 — Digital Toolkit for Skin Diseases in LMICs · NA · unknown
- NCT04858295 — Supporting Self-Management of Healthy Behaviors in Chronic Kidney Disease · NA · completed
- NCT05724966 — Anti-neoplastic Treatment, Based on PRO Data Reported Through a MHealth App Solution in Multiple Myeloma · completed
Other recruiting trials for Skin Diseases
Currently open trials in the same condition.
- NCT07412691 — A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases · Phase 1 · recruiting
- NCT07091604 — An Observational Study to Assess Objective Skin Pigmentation Variation. · recruiting
- NCT07158879 — Skin Reactions Related to Thoracic Implantable Chamber Dressings · recruiting
- NCT06850311 — Herbal Ointment in Treating Atopic Dermatitis Topically · Phase 2, PHASE3 · recruiting
- NCT06563323 — Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG) · Phase 2 · recruiting
Other Tulane University trials
Trials by the same sponsor.
- NCT04007276 — The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients · Phase 4 · not yet recruiting
- NCT07062406 — Enhancing Diabetes Care by Treating Insomnia · NA · not yet recruiting
- NCT06810739 — The Women's Screening and Self-Testing Program (PROMETA) Study · NA · not yet recruiting
- NCT05197998 — Promoting ColorBRAVE Conversations in Families · NA · suspended
- NCT06261840 — Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06292260 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tulane University
- Last refreshed: 17 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06292260.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing